SUDARSHAN PHARMA INDUSTRIES LI Share Price

SUDARSHAN PHARMA INDUSTRIES LI Share Price

BSE: 543828
|
Pharmaceuticals
|
S Cap
₹ 35.90
-₹0.16 (-0.44%)
1D
Last updated 14 Aug, 2026, 10:40 IST

SUDARSHAN PHARMA INDUSTRIES LI Share Price Today

As of 14 Aug 2026, SUDARSHAN PHARMA INDUSTRIES LI share price is ₹35.90. The stock opened at ₹36.15, compared to its previous close of ₹36.06. During today's trading session, SUDARSHAN PHARMA INDUSTRIES LI share price moved in the range of ₹35.35 to ₹37.50, with an average price of ₹36.42 for the day. Looking at its last 52-week, the stock has touched a low of ₹18.50 and a high of ₹42.79.

₹35.35
0.44% down today
₹37.50
1D LOW
1D HIGH

SUDARSHAN PHARMA INDUSTRIES LI Returns Calculator

Circuit
L
H
₹34.26
₹37.86
52-week
L
H
₹18.50
₹42.79

About SUDARSHAN PHARMA INDUSTRIES LI

SUDARSHAN PHARMA INDUSTRIES LI Share Price
ISIN
INE00TV01023
Sector Market Cap
₹ 867.82 Cr

Sudarshan Pharma Industries Limited is an India-based company, which is engaged in manufacturing, having a plant for API and doing jobwork manufacturing in Pharmaceutical Items and traders in Chemicals and Solvents in India. The Company is involved in specialty chemicals and intermediates for pharma, agricultural chemicals, coating, paints, adhesive, and various other industries. It is also focused on active pharmaceutical ingredient manufacturing. It is also into specialty chemicals imports and exports, as well as supplying the same to the actual users. The Company provides customized specialty chemicals to its clients in India and abroad regularly. The Company is involved in contract manufacturing, outsourcing and supplying generic pharma formulations and medicines to healthcare institutions, governments, non-governmental organizations (NGO) and hospitals. The Company operates in the states of Maharashtra, Gujarat and Uttarakhand.

SUDARSHAN PHARMA INDUSTRIES LI Financial Highlights

  • Revenue: SUDARSHAN PHARMA INDUSTRIES LI reported revenue of ₹711.77 crore in FY26 vs ₹507.70 crore in FY25. It showed an increase of 40.19% on a yearly basis.
  • Operating Profit: SUDARSHAN PHARMA INDUSTRIES LI reported an operating profit of ₹30.54 crore in FY26 vs ₹20.02 crore in FY25. It showed an increase of 52.55% on a year-on-year basis.
  • Net Profit: SUDARSHAN PHARMA INDUSTRIES LI reported a net profit of ₹23.37 crore in FY26 vs ₹14.97 crore in FY25. It showed an increase of 56.11% on a yearly basis.

SUDARSHAN PHARMA INDUSTRIES LI Quarterly Result Highlights

  • SUDARSHAN PHARMA INDUSTRIES LI reported revenue of ₹225.05 crore in Mar 2026, compared with ₹169.53 crore in Dec 2025, representing an increase of 32.75% on a quarter-on-quarter (QoQ) basis.
  • SUDARSHAN PHARMA INDUSTRIES LI reported an operating profit of ₹15.70 crore in Mar 2026, compared with ₹5.20 crore in Dec 2025, representing an increase of 201.92% on a quarter-on-quarter (QoQ) basis.
  • SUDARSHAN PHARMA INDUSTRIES LI reported a profit of ₹11.39 crore in Mar 2026, compared with ₹4.15 crore in Dec 2025, reflecting an increase of 174.46% on a QoQ basis.
  • The earnings per share (EPS) of SUDARSHAN PHARMA INDUSTRIES LI stood at ₹0.66 during Mar 2026.
Know more
Promoters
58.93%
FII
19.87%
Other DII
0.00%
Retail and other
21.20%
Mutual funds
0.00%
Foreign institutions - FII
FII shareholding by period
Dec 202519.78%
Mar 202619.95%
Jun 202619.38%
Aug 202619.87%
Mkt Cap Cr
867.82
P/E
34.67
P/B
5.60
ROE
15.03%
D/E
1.85
ROCE
12.76%
Div. Yield
0.00%
EPS(TTM)
0.91
Turnover
1.16
EV/EBITDA
17.17
Net Margin
0.00%
Op. Margin
0.00%
ROA
3.90%
Quick Ratio
0.00
Curr. Ratio
2.81
Based on fundamentals, this stock's
Step 1 of 5
Performance
Very Poor
Sudarshan Pharma has not beaten FD return of 7%
Step 1 of 5
Valuation
Overvalued
Sudarshan Pharma appears overvalued compared to its peers
Step 5 of 5
Earnings
Excellent
Sudarshan Pharma revenue, operating profit and net profit are growing
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROED/EROCEBook ValueDiv. YieldTurnoverEPS(TTM)
Pidilite Industries1,71,610.0064.2415.8722.61%0.0329.97%104.790.68%0.9823.43
SRF77,125.3035.325.4413.07%0.2713.18%426.520.35%0.6558.18
Linde India57,669.80104.4813.3812.87%0.0217.16%495.720.18%0.4664.59
Gujarat Fluorochemicals51,725.1086.216.627.13%0.228.93%647.240.06%0.4761.69
Navin Fluorine42,546.9053.8810.7016.69%0.0318.14%714.490.10%0.5696.03
Godrej Industries41,626.4020.312.2518.01%6.259.86%52.520.00%0.341.81
Himadri Speciality Chemicals38,461.2048.808.3415.96%0.1619.45%91.620.10%0.7515.05
Deepak Nitrite23,210.0029.633.989.43%0.0210.74%235.740.44%0.7413.85
Aether Industries20,982.3089.218.548.94%0.1510.61%181.530.00%0.3313.09
Atul20,321.3025.023.2610.90%0.0014.31%2,056.910.44%0.80202.11

SUDARSHAN PHARMA INDUSTRIES LI Financials

Full statement

Income Statement · Consolidated

Income Statement · Consolidated — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Revenue₹505.05₹463.54₹461.33₹357.09
Other Income₹2.52₹2.61₹1.12₹0.46
Total Revenue₹507.57₹466.15₹462.45₹357.56
Total Expenses₹483.12₹450.92₹452.95₹350.42
Profit Before Tax₹21.63₹15.23₹9.50₹7.14
Tax₹5.68₹3.77₹2.46₹1.89
Profit After Tax₹15.95₹11.46₹7.04₹5.25
EPS - Basic₹0.66₹4.76₹5.48₹5.46
EPS - Diluted₹0.66₹4.76₹5.48₹5.46

Cash Flow · Consolidated

Cash Flow · Consolidated — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Profit before tax₹21.63₹15.23₹9.50₹7.14
Income before WC changes₹41.64₹24.63₹15.32₹11.18
Change in Assets-₹100.01-₹52.18-₹57.56-₹42.96
Change in Liabilities₹96.53₹35.72₹15.56₹29.72
Change in WC-₹3.48-₹16.46-₹42.00-₹13.24
Cash flow from Operations₹35.22₹6.01-₹28.79-₹3.82
Cash flow from Investing-₹20.41-₹5.49-₹25.65-₹1.46
Cash flow from Financing-₹14.45-₹12.10₹65.93₹4.26
Total Cash Flow₹0.37-₹11.58₹11.48-₹1.02
Cash (Start of the year)₹0.14₹11.72₹0.24₹1.25
Cash (End of the year)₹0.55₹0.14₹11.72₹0.24

Balance Sheet · Consolidated

Balance Sheet · Consolidated — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Non-Current Assets₹67.56₹41.55₹33.86₹7.94
Current Assets₹334.85₹241.57₹198.62₹129.58
Total Assets₹402.41₹283.13₹232.48₹137.52
Current Liabilities₹259.69₹160.82₹118.48₹102.62
Net Current Asset₹75.15₹80.75₹80.14₹26.96
Non-Current Liabilities₹11.23₹10.59₹13.03₹5.12
Equity Capital₹131.48₹111.71₹100.97₹29.78
Total Equity & Liabilities₹402.41₹283.13₹232.48₹137.52

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Revenue₹502.51₹465.56₹461.33₹357.09
Other Income₹2.88₹2.75₹1.12₹0.46
Total Revenue₹505.38₹468.31₹462.45₹357.56
Total Expenses₹481.28₹453.22₹452.95₹350.42
Profit Before Tax₹21.29₹15.10₹9.50₹7.14
Tax₹5.41₹3.74₹2.46₹1.89
Profit After Tax₹15.88₹11.36₹7.04₹5.25
EPS - Basic₹0.66₹0.47₹5.48₹5.46
EPS - Diluted₹0.66₹0.47₹5.48₹5.46

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Profit before tax₹21.29₹15.10₹9.50₹7.14
Income before WC changes₹40.21₹24.42₹15.32₹11.22
Change in Assets-₹95.54-₹55.03-₹57.56-₹42.85
Change in Liabilities₹93.07₹42.42₹15.56₹29.71
Change in WC-₹2.46-₹12.62-₹42.00-₹13.15
Cash flow from Operations₹34.91₹9.69-₹28.79-₹3.70
Cash flow from Investing-₹20.24-₹9.08-₹25.65-₹1.54
Cash flow from Financing-₹14.41-₹12.18₹65.93₹4.31
Total Cash Flow₹0.26-₹11.58₹11.48-₹0.93
Cash (Start of the year)₹0.13₹11.71₹0.23₹1.15
Cash (End of the year)₹0.39₹0.13₹11.71₹0.23

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Non-Current Assets₹66.57₹43.99₹33.96₹8.04
Current Assets₹333.83₹240.85₹198.51₹129.47
Total Assets₹400.40₹284.84₹232.47₹137.51
Current Liabilities₹257.98₹162.27₹118.46₹102.61
Net Current Asset₹75.85₹78.58₹80.05₹26.86
Non-Current Liabilities₹11.10₹10.96₹13.03₹5.12
Equity Capital₹131.31₹111.62₹100.98₹29.78
Total Equity & Liabilities₹400.40₹284.84₹232.47₹137.51
* All values are in INR Crore
Qty
Bid
4000
35.52
4000
35.5
4000
35.35
4000
35.32
4000
35.25
Ask
Qty
36
8000
36.74
4000
36.75
8000
37.39
4000
37.4
8000
Bid Total: 20000
Ask Total: 32000
Buy orders: 38%
Sell orders: 62%
Bearish
2
Neutral
6
Bullish
0
Slightly Bearish
by SEBI experts
Expert Pick
EXPPICK
Stop-loss
Entry price
Target
Indicator
Value
Verdict
RSI (14)
47.26
Neutral
ATR (14)
2.32
Neutral
STOCH(9,6)
69.7
Neutral
STOCH RSI (14)
60.78
Neutral
ADX(9)
47.98
Bearish
UO(9)
61.1
Neutral
ROC(12)
-9.21
Bearish
WillR(14)
-54.5
Neutral
Period
Simple value
Exponential vaue
5D
34.16
34.74
10D
34.53
35.23
20D
37.55
36.48
50D
37.85
36.61
100D
33.81
34.38
Volume trend — traded volume by day
14 Aug10L
13 Aug25L
12 Aug28L
11 Aug14L
10 Aug2L
7 Aug9L
Average15L
Compare against other stocks
SUDARSHAN PHARMA INDUSTRIES LI Share Price
SUDARSHAN PHARMA INDUSTRIES LI
Pharmaceuticals
Add Stock
Add Another

SUDARSHAN PHARMA INDUSTRIES LI Share Price FAQs